BrainsWay Ltd. (TLV:BWAY)
2,546.00
-104.00 (-3.92%)
Aug 28, 2025, 5:24 PM IDT
BrainsWay Market Cap
BrainsWay has a market cap or net worth of 955.67 million as of August 28, 2025. Its market cap has increased by 120.73% in one year.
Market Cap
955.67M
Enterprise Value
713.53M
Revenue
155.27M
Ranking
n/a
PE Ratio
67.95
Stock Price
2,546.00
Market Cap Chart
Since September 24, 2007, BrainsWay's market cap has increased from 101.45M to 955.67M, an increase of 842.00%. That is a compound annual growth rate of 13.32%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 28, 2025 | 955.67M | 45.47% |
Dec 31, 2024 | 656.96M | 72.83% |
Dec 31, 2023 | 380.12M | 223.68% |
Dec 29, 2022 | 117.44M | -70.48% |
Dec 30, 2021 | 397.80M | 56.55% |
Dec 31, 2020 | 254.10M | -32.02% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 69.94B |
Danel (Adir Yeoshua) | 2.85B |
Kamada | 1.36B |
Bait Bakfar | 1.04B |
SofWave Medical | 980.26M |
Novolog (Pharm-Up 1966) | 759.16M |
Ilex Medical | 685.16M |
Bonus BioGroup | 284.97M |